Form D — Montara Therapeutics, Inc.
0002008775-25-000001 · filed 2025-03-13
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $19,999,995
- Total sold
- $19,999,995
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Montara Therapeutics, Inc.
- CIK
- 2008775
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 135 MISSISSIPPI STREET
SAN FRANCISCO, CA 94107 - Phone
- 310-463-6172
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Nicholas Hertz · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Dirk Langdorf · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Seth Stratton · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Troy Wilson · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Max Lebovitz · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Randall Chin · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Rishi Rakhit · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Zachary Hill · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
View original on SEC EDGAR.